Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
JAPAN
Jan 14, 2022
Pfizer seeks approval for oral COVID-19 pill in Japan
The country has already agreeing to procure enough of the drug, Paxlovid, for 2 million people
Japan Times
WORLD / Science & Health
Jan 12, 2022
Biogen stung as U.S. limits coverage of Alzheimer’s therapy
Private insurers in the U.S. have mostly declined to cover Aduhelm, saying they need more proof of its efficacy and that benefits outweigh risks like brain swelling.
Japan Times
WORLD / Science & Health
Jan 11, 2022
Singapore breaks down COVID-19 deaths by vaccine, with Moderna seeing lowest rate
While there were some caveats, the findings will likely add to concerns around the efficacy of Sinovac's and Sinopharm Group's shots, which have been widely used in the developing world.
Japan Times
WORLD / Science & Health
Jan 11, 2022
Pfizer starts making vaccine that targets both omicron and the original COVID virus
While research continues, Pfizer will evaluate the new hybrid shot against one specific to omicron and determine which should move forward by March, the firm's CEO has said.
Japan Times
BUSINESS
Dec 27, 2021
Tardy COVID-19 vaccine makers under fire for trials in developing nations
Vaccine developers at the testing phase now are seeking developing countries where vaccination rates remain low and the virus is still active.
Japan Times
JAPAN / Science & Health
Dec 24, 2021
Japan government panel approves first oral COVID-19 pill
Clinical trial data shows that patients given the pill within five days of developing symptoms were 30% less likely to be hospitalized or die.
Japan Times
WORLD
Dec 23, 2021
Pfizer pill adds to growing U.S. stockpile of COVID-19 treatments
Infections are rising across the country, but the treatments will give doctors a larger arsenal with which to fight severe coronavirus cases.
Japan Times
JAPAN / FOCUS
Dec 21, 2021
Ivermectin for COVID? Unproven treatment stokes concern in Japan
Although the treatment has received some support from Japan's medical establishment and studies are ongoing, ivermectin is not approved as a COVID-19 remedy in the country.
Japan Times
WORLD / Science & Health
Dec 20, 2021
Moderna says its booster dose appears protective against omicron
The data, which has not yet been peer reviewed, tested blood from people who had received the vaccine against a pseudovirus engineered to resemble the omicron variant.
Japan Times
JAPAN
Dec 18, 2021
Japan to shorten booster shot interval for medical workers and seniors on omicron concerns
The interval between second shots and booster shots will be six months for health care workers and those living in nursing homes, the prime minister said.
Japan Times
WORLD / Science & Health
Dec 3, 2021
Six vaccines show promise as boosters, led by mRNA shots
Researchers tested the vaccines in more than 2,800 volunteers 30 and older who had already received two doses of the AstraZeneca or Pfizer shots.
Japan Times
JAPAN / Science & Health
Nov 30, 2021
Japanese drugmaker Shionogi considers developing vaccine for omicron variant
The company is currently conducting a final clinical trial of its COVID-19 vaccine, aiming to make it available in March.
Japan Times
BUSINESS / Companies
Nov 25, 2021
SoftBank’s Masayoshi Son bets on narcolepsy drug for sleep-deprived Japan
The proportion of people sleeping less than the recommended eight hours is rising globally, and costs Japan as much as $138 billion in economic losses each year, according to Rand Corp.
Japan Times
JAPAN
Nov 12, 2021
Takeda applies for approval of Moderna's booster shots in Japan
A government subcommittee of health experts will discuss the use of the vaccine as a booster shot in late December at the earliest.
Japan Times
WORLD
Nov 9, 2021
Regeneron antibody prevents COVID-19 infections for eight months
The company has asked the U.S. Food and Drug Administration to expand the authorization so the drug can be used to prevent infections.
Japan Times
WORLD / Science & Health
Nov 5, 2021
Pfizer develops COVID-19 pill that cuts hospitalizations and deaths by 89%
The drugmaker claims 'overwhelming efficacy” and plans to submit their findings for emergency authorization as soon as possible.
Japan Times
WORLD
Oct 15, 2021
U.S. FDA advisers back Moderna COVID-19 booster shots for older and high-risk people
If the FDA signs off on Moderna's booster, the U.S. Centers for Disease Control and Prevention will make specific recommendations on who should get the shots.
Japan Times
WORLD
Oct 11, 2021
AstraZeneca drug effective at treating mild COVID-19 symptoms in trial
The antibody cocktail from AstraZeneca may offer a simple way of treating patients before they ever visit the hospital.
Japan Times
WORLD
Oct 11, 2021
Moderna, racing for profits, keeps COVID-19 vaccine out of reach of poor
Moderna has shipped a greater share of its doses to wealthy countries than any other vaccine manufacturer, a data-tracking firm has said.
Japan Times
WORLD
Oct 8, 2021
Pfizer seeks U.S. COVID-19 vaccine clearance for children age 5 to 11
The Food and Drug Administration has set a date of Oct. 26 for its panel of outside advisers to meet and discuss the application.

Longform

Things may look perfect to the outside world, but today's mom is fine with some imperfection at home.
How 'Reiwa moms' are reshaping motherhood in Japan